[EN] NEW DIAZASPIROCYCLOALKANE AND AZASPIROCYCLOALKANE<br/>[FR] NOUVEAUX COMPOSÉS DIAZASPIROCYCLOALCANE ET AZASPIROCYCLOALCANE
申请人:HOFFMANN LA ROCHE
公开号:WO2013186159A1
公开(公告)日:2013-12-19
The invention provides novel compounds having the general formula (I), wherein R1, R2, Y and W are as described herein, compositions including the compounds and methods of using the compounds.
Compounds having the general formula (I)
wherein R1, R2, Y and W are as described herein, compositions including the compounds and methods of using the compounds as autotaxin inhibitors.
具有通式 (I) 的化合物
其中 R1、R2、Y 和 W 如本文所述,包括这些化合物的组合物以及将这些化合物用作自体表皮生长因子抑制剂的方法。
DIAZASPIROCYCLOALKANE AND AZASPIROCYCLOALKANE
申请人:Hoffmann-La Roche Inc.
公开号:US20200207769A1
公开(公告)日:2020-07-02
Compounds having the general formula (I)
wherein R
1
, R
2
, Y and W are as described herein, compositions including the compounds and methods of using the compounds as autotaxin inhibitors.
US9493486B2
申请人:——
公开号:US9493486B2
公开(公告)日:2016-11-15
NEW DIAZASPIROCYCLOALKANE AND AZASPIROCYCLOALKANE
申请人:Hoffmann-La Roche Inc.
公开号:US20150099734A1
公开(公告)日:2015-04-09
The invention provides novel compounds having the general formula (I)
wherein R
1
, R
2
, Y and W are as described herein, compositions including the compounds and methods of using the compounds.